Agendia Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 196

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Latest Deal Amount
  • $75M

  • Investors
  • 10

Agendia General Information

Description

Developer of genomic diagnostic products designed to provide treatment for cancer. The company uses Deoxyribonucleic Acid (DNA) microarray technology and develops products by analyzing the complete human genome, enabling physicians to make complex treatment decisions.

Contact Information

Website
www.agendia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 22 Morgan
  • Irvine, CA 92618
  • United States
+1 (888)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 22 Morgan
  • Irvine, CA 92618
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Agendia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. IPO 28-Oct-2021 $75M Cancelled Generating Revenue
12. Debt - PPP 04-May-2020 Completed Generating Revenue
11. Later Stage VC 25-Jul-2018 Completed Generating Revenue
10. Grant 16-Dec-2015 Completed Generating Revenue
9. Grant 20-Mar-2015 Completed Generating Revenue
8. Debt - General 14-Mar-2014 Completed Generating Revenue
7. Later Stage VC 31-May-2012 Completed Generating Revenue
6. IPO 21-Jun-2011 Cancelled Generating Revenue
5. Later Stage VC (Series E) 22-Sep-2009 $23M $57M Completed Generating Revenue
4. Later Stage VC (Series D) 28-Aug-2007 $34M $34M Completed Generating Revenue
To view Agendia’s complete valuation and funding history, request access »

Agendia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genomic diagnostic products designed to provide treatment for cancer. The company uses Deoxyribonucleic Aci
Diagnostic Equipment
Irvine, CA
196 As of 2023

Boston, MA
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Agendia Competitors (53)

One of Agendia’s 53 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Boston, MA
RareCyte Venture Capital-Backed Seattle, WA
Akonni Biosystems Venture Capital-Backed Frederick, MD
Illumina Formerly VC-backed San Diego, CA
New Day Diagnostics Venture Capital-Backed Knoxville, TN
You’re viewing 5 of 53 competitors. Get the full list »

Agendia Patents

  • 91

    Total Documents Applications and Grants

  • Total Patents Families

  • 25

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Agendia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025198469-A1 Prediction of response to immune therapy in triple negative breast cancer patients. Pending 18-Mar-2024
WO-2025159640-A1 Method for assessing a risk of breast cancer recurrence Pending 24-Jan-2024
EP-4526471-A1 Dna repair signature and prediction of response following cancer therapy Pending 19-May-2022
US-20260110035-A1 Dna repair signature and prediction of response following cancer therapy Pending 19-May-2022
WO-2023224488-A1 Dna repair signature and prediction of response following cancer therapy Inactive 19-May-2022 C12Q1/6886
To view Agendia’s complete patent history, request access »

Agendia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Agendia Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Athyrium Capital Management Asset Manager Minority
Horizon 2020 Government Minority
Breedinvest Asset Manager Minority
Debiopharm Innovation Fund Corporate Venture Capital Minority
Korys Investments Family Office Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Agendia FAQs

  • When was Agendia founded?

    Agendia was founded in 2003.

  • Where is Agendia headquartered?

    Agendia is headquartered in Irvine, CA.

  • What is the size of Agendia?

    Agendia has 196 total employees.

  • What industry is Agendia in?

    Agendia’s primary industry is Diagnostic Equipment.

  • Is Agendia a private or public company?

    Agendia is a Private company.

  • What is Agendia’s current revenue?

    The current revenue for Agendia is .

  • How much funding has Agendia raised over time?

    Agendia has raised $178M.

  • Who are Agendia’s investors?

    Athyrium Capital Management, Horizon 2020, Breedinvest, Debiopharm Innovation Fund, and Korys Investments are 5 of 10 investors who have invested in Agendia.

  • Who are Agendia’s competitors?

    Foundation Medicine, RareCyte, Akonni Biosystems, Illumina, and New Day Diagnostics are some of the 53 competitors of Agendia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process